Syndax Pharmaceuticals (SNDX) Prepaid Assets (2015 - 2026)
Syndax Pharmaceuticals (SNDX) posted quarterly Prepaid Assets of $980000.0 for Q1 2026, up 2700.0% year-over-year from $35000.0 in Q1 2025, and up 1681.82% quarter-over-quarter from $55000.0 in Q4 2025.
Analysis
Syndax Pharmaceuticals (SNDX) Prepaid Assets (2015 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Prepaid Assets history runs 12 years deep, the most recent figure standing at $980000.0 for Q1 2026.
- In Q1 2026, Prepaid Assets rose 2700.0% year-over-year to $980000.0; the TTM figure through Mar 2026 stood at $980000.0 (up 2700.0% YoY), while the FY2025 annual figure was $55000.0, down 91.01% from the prior year.
- Prepaid Assets for Q1 2026 stood at $980000.0, up from $55000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $9.5 million in Q3 2025, with the low at $18000.0 in Q2 2025.
- The 5-year median for Prepaid Assets is $1.6 million (2022), against an average of $2.0 million.
- The sharpest annual moves came in 2025 and 2026: Prepaid Assets sank 99.57% in 2025, then surged 2700.0% in 2026.
- Syndax Pharmaceuticals' Prepaid Assets stood at $1.9 million in 2022, then jumped by 71.96% to $3.3 million in 2023, then slumped by 81.42% to $612000.0 in 2024, then sank by 91.01% to $55000.0 in 2025, then soared by 1681.82% to $980000.0 in 2026.
- Business Quant data shows SNDX's Prepaid Assets at $980000.0 in Q1 2026, $55000.0 in Q4 2025, and $9.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Syndax Pharmaceuticals | 1.83 Bn | 1.28 Bn | 60.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.48 Mn |
| Mar 31, 2026 | 16.10 Mn |
| Dec 31, 2025 | 13.50 Mn |
| Sep 30, 2025 | 9.52 Mn |
| Jun 30, 2025 | 9.88 Mn |
| Mar 31, 2025 | 8.46 Mn |
| Dec 31, 2024 | 8.54 Mn |
| Sep 30, 2024 | 4.91 Mn |
| Jun 30, 2024 | 9.58 Mn |
| Mar 31, 2024 | 6.07 Mn |
| Dec 31, 2023 | 3.29 Mn |
| Sep 30, 2023 | 3.75 Mn |
| Jun 30, 2023 | 3.06 Mn |
| Mar 31, 2023 | 1.91 Mn |
| Dec 31, 2022 | 1.92 Mn |
| Sep 30, 2022 | 2.27 Mn |
| Jun 30, 2022 | 2.39 Mn |
| Mar 31, 2022 | 9.03 Mn |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | 8.42 Mn |